BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 27738827)

  • 1. Prognostic Impact of Node-Spreading Pattern in Surgically Treated Small-Cell Lung Cancer: A Multicentric Analysis.
    Leuzzi G; Lococo F; Alessandrini G; Sperduti I; Spaggiari L; Venuta F; Rendina EA; Granone PM; Rapicetta C; Zannini P; Di Rienzo G; Nicolosi M; Facciolo F
    Lung; 2017 Feb; 195(1):107-114. PubMed ID: 27738827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
    Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative long-term survival of non-small cell lung cancer patients with skip-N2 metastases.
    Schlachtenberger G; Doerr F; Menghesha H; Heldwein MB; Hagmeyer L; Michel M; Schaefer SC; Wahlers T; Hekmat K
    Surg Oncol; 2021 Sep; 38():101505. PubMed ID: 33901730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of postoperative radiotherapy in multimodality treatment of resected small-cell lung cancer with lymph node metastasis.
    Liu WS; Zhao LJ; Wang S; Gong LL; Liu ZY; Yuan ZY; Wang P
    Eur J Surg Oncol; 2014 Sep; 40(9):1156-62. PubMed ID: 24655801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with non-small cell lung cancer according to lymph node disease: single pN1 vs multiple pN1 vs single unsuspected pN2.
    Macia I; Ramos R; Moya J; Rivas F; Ureña A; Banque M; Escobar I; Rosado G; Rodriguez-Taboada P
    Ann Surg Oncol; 2013 Jul; 20(7):2413-8. PubMed ID: 23378017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapy.
    Lee H; Ahn YC; Pyo H; Kim B; Oh D; Nam H; Lee E; Sun JM; Ahn JS; Ahn MJ; Park K; Choi YS; Kim J; Zo JI; Shim YM
    Ann Surg Oncol; 2014 Jun; 21(6):2083-90. PubMed ID: 24522994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
    Fukui T; Mori S; Yokoi K; Mitsudomi T
    J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
    Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant prognostic factors for completely resected pN2 non-small cell lung cancer without neoadjuvant therapy.
    Uehara H; Nakao M; Mun M; Nakagawa K; Nishio M; Ishikawa Y; Okumura S
    Ann Thorac Cardiovasc Surg; 2015; 21(4):345-53. PubMed ID: 25740454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resectable left lower lobe non-small cell lung cancer with lymph node metastasis is related to unfavorable outcomes.
    Ye WF; Xie X; Yang H; Luo KJ; Liu QW; Zheng YZ; Wang JY
    Chin J Cancer; 2016 Jan; 35():7. PubMed ID: 26738896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
    Park S; Cho S; Yum SW; Kim K; Jheon S
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of radiotherapy between postoperative mediastinal lymph node recurrence and stage III disease in non-small cell lung cancer patients.
    Imai H; Murakami H; Yoshino R; Mori K; Sumita K; Ono A; Akamatsu H; Taira T; Kenmotsu H; Harada H; Naito T; Kaira K; Tomizawa Y; Ohde Y; Matsuura M; Endo M; Saito R; Nakajima T; Takahashi T
    J BUON; 2016; 21(2):333-40. PubMed ID: 27273942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
    Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
    World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
    Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of node involvement pattern in pulmonary pN1 squamous cell carcinoma patients.
    Nakao M; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    J Thorac Oncol; 2010 Apr; 5(4):504-9. PubMed ID: 20104192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer].
    Wu XW; Chen T; Yin S; Deng Y; Zhao B
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):782-786. PubMed ID: 30392344
    [No Abstract]   [Full Text] [Related]  

  • 19. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
    Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
    Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.